Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease

2.50
Hdl Handle:
http://hdl.handle.net/2336/10697
Title:
Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease
Authors:
Olafsdottir, Eydis; Andersson, Dan K; Stefansson, Einar
Citation:
Acta Ophthalmol Scand 2007, 85(1):40-5
Issue Date:
1-Feb-2007
Abstract:
PURPOSE: Regular screening for both diabetes mellitus and diabetic eye disease should be the gold standard in preventing diabetic blindness. In the community of Laxå, County of Orebro, Sweden, such screening has been carried out since 1983. We evaluate visual impairment and blindness in this population. METHODS: All persons in the community of Laxå with a diagnosis of type 2 diabetes mellitus (n = 276) participated in the study. An age- and gender-matched control group (n = 259) was assembled. Best corrected visual acuity (BCVA) was tested in all participants, and a detailed eye examination performed by an ophthalmologist. RESULTS: No significant statistical differences were seen between the diabetes and control groups regarding visual acuity (VA). In all, 2.9% of the diabetes patients and 1.2% of the controls had BCVA < or = 0.1. Only one person in the diabetes group was blind as a result of diabetic retinopathy. In both groups the leading cause of blindness was age-related macular degeneration. In a logistic regression analysis we found that in both the diabetes and the control populations, increasing age was related to worsening BCVA (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.10-1.16 versus OR 1.16, 95% CI 1.13-1.19), as was female gender in the diabetes group only (OR 2.73, 95% CI 1.69-4.40). CONCLUSIONS: In a population that is carefully screened for diabetes mellitus and provided with regular screening for diabetic retinopathy, the loss of vision from diabetic retinopathy is uncommon.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-0420.2006.00753.x

Full metadata record

DC FieldValue Language
dc.contributor.authorOlafsdottir, Eydis-
dc.contributor.authorAndersson, Dan K-
dc.contributor.authorStefansson, Einar-
dc.date.accessioned2007-03-19T13:46:50Z-
dc.date.available2007-03-19T13:46:50Z-
dc.date.issued2007-02-01-
dc.date.submitted2007-03-19-
dc.identifier.citationActa Ophthalmol Scand 2007, 85(1):40-5en
dc.identifier.issn1395-3907-
dc.identifier.pmid17244208-
dc.identifier.doi10.1111/j.1600-0420.2006.00753.x-
dc.identifier.otherOPH12-
dc.identifier.urihttp://hdl.handle.net/2336/10697-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractPURPOSE: Regular screening for both diabetes mellitus and diabetic eye disease should be the gold standard in preventing diabetic blindness. In the community of Laxå, County of Orebro, Sweden, such screening has been carried out since 1983. We evaluate visual impairment and blindness in this population. METHODS: All persons in the community of Laxå with a diagnosis of type 2 diabetes mellitus (n = 276) participated in the study. An age- and gender-matched control group (n = 259) was assembled. Best corrected visual acuity (BCVA) was tested in all participants, and a detailed eye examination performed by an ophthalmologist. RESULTS: No significant statistical differences were seen between the diabetes and control groups regarding visual acuity (VA). In all, 2.9% of the diabetes patients and 1.2% of the controls had BCVA < or = 0.1. Only one person in the diabetes group was blind as a result of diabetic retinopathy. In both groups the leading cause of blindness was age-related macular degeneration. In a logistic regression analysis we found that in both the diabetes and the control populations, increasing age was related to worsening BCVA (odds ratio [OR] 1.13, 95% confidence interval [CI] 1.10-1.16 versus OR 1.16, 95% CI 1.13-1.19), as was female gender in the diabetes group only (OR 2.73, 95% CI 1.69-4.40). CONCLUSIONS: In a population that is carefully screened for diabetes mellitus and provided with regular screening for diabetic retinopathy, the loss of vision from diabetic retinopathy is uncommon.en
dc.language.isoenen
dc.publisherMunksgaarden
dc.relation.urlhttp://www.blackwell-synergy.com/doi/abs/10.1111/j.1600-0420.2006.00753.xen
dc.subject.meshAdulten
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshBlindnessen
dc.subject.meshDiabetes Mellitus, Type 2en
dc.subject.meshDiabetic Retinopathyen
dc.subject.meshFemaleen
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMiddle Ageden
dc.subject.meshOdds Ratioen
dc.subject.meshPrevalenceen
dc.subject.meshRural Populationen
dc.subject.meshSweden/epidemiologyen
dc.subject.meshVision Screeningen
dc.subject.meshVision, Lowen
dc.subject.meshVisual Acuityen
dc.subject.meshVisually Impaired Personsen
dc.titleVisual acuity in a population with regular screening for type 2 diabetes mellitus and eye diseaseen
dc.typeArticleen
dc.identifier.journalActa ophthalmologica Scandinavicaen
dc.format.digYES-

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.